Jd. Miranda et Em. Barnes, REPRESSION OF GAMMA-AMINOBUTYRIC-ACID TYPE-A RECEPTOR ALPHA-1-POLYPEPTIDE BIOSYNTHESIS REQUIRES CHRONIC AGONIST EXPOSURE, The Journal of biological chemistry, 272(26), 1997, pp. 16288-16294
Although it is well established that the number of gamma-aminobutyric
acid type A (GABA(A)) receptors declines in cortical neurons exposed t
o GABA(A) receptor agonists, the mechanisms responsible for this use-d
ependent down-regulation remain unclear. Two hypotheses have been prop
osed: (i) agonist-evoked sequestration and degradation of surface GABA
(A) receptors and (ii) repression of receptor subunit biosynthesis. We
have addressed this problem using [S-35]Met/Cys pulse-chase labeling
of chick cortical newtons in culture and immunoprecipitation and immun
oblotting with an antibody (RP4) directed against a GABA(A) receptor a
lpha(1)-(331-381) fusion protein. Exposure of the cells to GABA or iso
guvacine for 2 h to 4 days had no effect on the initial rate of S-35 i
ncorporation into the GABA(A) receptor 51-kDa alpha 1 polypeptide, but
this rate declined by 33% after a 7-day treatment, This is consistent
with a previous report (Baumgartner, B. J., Harvey, R. J., Darlison,
M. G., and Barnes, E. M. (1994) Mol. Brain Res. 26, 9-17) that a 7-day
GABA treatment of this preparation produced a 45% reduction in the al
pha 1 subunit mRNA level, while a 4-day exposure had no detectable eff
ect. On the other hand, after a 4-day exposure to these agonists, a 30
% reduction in the level of the alpha 1 polypeptide was observed on im
munoblots, similar to that found previously for down-regulation of GAB
A(A) receptor ligand-binding sites, Thus, the de nova synthesis of GAB
A(A) receptor alpha 1 subunits is subject to a delayed use-dependent r
epression that was observed after, rather than before, the decline in
neuronal levels of the polypeptide. Pulse-chase experiments showed a m
onophasic degradation of the GABA(A) receptor S-35-alpha 1 subunit Wit
h a t(1/2) = 7.7 h, a process that was unaffected by the addition of G
ABA to neurons during the chase period. These nascent S-35-labeled pol
ypeptides are presumably diluted into the neuronal pool of unlabeled u
nassembled al subunits, which was found to exceed by a 4:1 molar ratio
the amount assembled into [H-3]flunitrazepam binding sites. Thus, the
data reveal an alternative scheme for degradation of GABA(A) receptor
polypeptides: a pathway that may participate in the agonist-independe
nt degradation of unassembled receptor subunits. This differs from ano
ther pathway for the agonist-dependent degradation of mature GABA(A) r
eceptors derived from the neuronal surface (Calkin, P. A. and Barnes,
E. M., Jr. (1994) J. Biol. Chem. 269, 1548-1553).